Dr. Fauci says it's 'doable' to have coronavirus vaccine with hundreds of millions of doses by January
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, believes it's "doable" to have hundreds of millions of doses of a coronavirus vaccine ready by January 2021.
Fauci appeared Thursday on Today after Bloomberg reported that a Trump administration program, Operation Warp Speed, aims to speed up development of a COVID-19 vaccine with the goal of having 300 million doses available by January.
Asked if this rapid timeline is actually possible, Fauci told Today that he believes it is, explaining that the plan is, as Bloomberg reported, to quickly move to ramp up production of some potential vaccines while they are undergoing trials but before it's clear if they work.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"We're going to start ramping up production with the companies involved, and you do that at risk," Fauci said. "In other words, you don't wait until you get an answer before you start manufacturing. You, at risk, proactively start making it assuming it's going to work. And if it does, then you could scale up and hopefully get to that timeline."
Fauci added of this quick timeline, "I think that is doable, if things fall in the right place." In its report on Operation Warp Speed, Bloomberg noted that "there is no precedent for such rapid development of a vaccine." Brendan Morrow
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
The Christmas quiz 2024
From the magazine Test your grasp of current affairs and general knowledge with our quiz
By The Week UK Published
-
People of the year 2024
In the Spotlight Remember the people who hit the headlines this year?
By The Week UK Published
-
Crossword: December 25, 2024
The Week's daily crossword
By The Week Staff Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published